Want to join the conversation?
$SYMC 1Q16 Call: Non-GAAP operating margin was 27.4%, an increase of 480 BPs YoverY, driven by lower spend as we aligned costs with lower revenue. We will continue to make operational improvements to our business to expand operating margin as we approach longer-term target of 30%. Non-GAAP net income of $275MM resulted in fully diluted EPS of $0.40
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)